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RESECTION OF LUNG CANCER INVADING THE DIAPHRAGM 
Benny Weksler, MD, Manjit Bains, MD, Michael Burt, MD, PhD, Robert Downey, MD, Nael Martini, MD, 
Valerie Rusch, MD, and Robert Ginsberg, MD, New York, N.Y. 
Each year, stage III non-small-cell ung cancer 
(NSCLC) is diagnosed in approximately 30,000 patients. 
Locally advanced NSCLC (stage IliA) includes a group of 
biologically diverse tumors with subgroups of truly locally 
advanced isease--T3 tumors and advanced locoregional 
disease with the presence of N2 disease. The prognosis of 
patients with a diagnosis of stage III lung cancer is mainly 
dependent on the status of the mediastinal nodes. Good 
long-term results are achieved in patients with NO disease, 
whereas patients with N2 disease are poor candidates for 
resection as a primary treatment. 1-3 Information is not 
available on results of surgical treatment of patients with 
stage III disease and tumors involving the diaphragm. 
Patients and methods. From January 31, 1974, to Au- 
gust 17, 1995, a total of 4668 patients underwent explora- 
tion for resection of NSCLC at Memorial Hospital. By 
analyzing our database we identified eight patients 
(0.17%) who had exploratory thoracotomy for resection of 
NSCLC invading the diaphragm. The medical records of 
these eight patients were retrospectively analyzed. Data 
are reported as mean -+ standard eviation. Survival data 
are reported as mean and 95% confidence interval (CI) 
for the mean. The Kaplan-Meier method was used to 
calculate actuarial survival. 
Results. The demographics of these eight patients are 
shown in Table I. The mean age at diagnosis was 65.8 + 
10.2 years, ranging from 52.6 to 82.4 years. The most 
common symptoms were cough in four patients, hemop- 
tysis in two patients, and chest pain in one patient. One 
patient had clubbing of the fingers. Three patients were 
free of symptoms. All patients moked. The mean time 
from first symptoms to referral for treatment was 25.1 -+ 
16.6 weeks, ranging from 5.3 to 49 weeks. The histologic 
diagnosis was made by bronchoscopic examination i four 
patients and by fluoroscopic guided needle biopsy in two. 
In two patients the diagnosis was made in the operating 
room. Four tumors were on the right side and four on the 
left side. Two patients underwent mediastinoscopy, both 
studies yielding negative results. The other six did not 
undergo preoperative mediastinoscopy. Among the eight 
patients, diaphragmatic nvasion was not suspected at 
exploration in six and it was suspected before the opera- 
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tion in one; the eighth patient was treated by exploration, 
immediate closure of the incision, subsequent chemother- 
apy and radiation therapy, and then complete resection. 
Surgical treatment included wedge resection in one pa- 
tient, lobectomy in four, bilobectomy in one, and right 
pneumonectomy in one. One patient was deemed to have 
unresectable disease and received radiotherapy via after- 
loading catheters. The diaphragm was resected en bloc 
with the tumor in seven patients, and all but one under- 
went primary closure of the diaphragm; one patient had 
reconstruction with polytetrafluoroethylene mesh. 
Seven patients had squamous cell carcinoma nd one 
patient had adenosquamous carcinoma. The tumor patho- 
logically invaded the diaphragmatic muscle in all resected 
specimens. Final pathologic stage was T3 NO in four 
patients and T3 N2 in four patients. All patients urvived 
the operation and were discharged from the hospital. 
Complications were minor. Mean hospital stay was 8.6 -+ 
9.4 days, ranging from 4 to 32 days. Follow-up data were 
complete on all patients. Survival was 52.8 weeks (95% CI 
12.4 to 93.1 weeks). Of the four patients with N2 disease, 
all died of recurrent disease with a mean survival of 92.1 
weeks (95% CI 28.4 to 155.8 weeks). Of patients with NO 
disease, one is alive 69.4 weeks after the operation and the 
other three died of causes unrelated to their disease. In 
four patients who had N2 disease, the recurrent disease 
occurred 53.6 -+ 75.0 weeks after the operation. The site 
of first recurrence was the brain in three patients and 
axillary node in one patient. Survival after recurrence was 
only 27.4 -+ 34.1 weeks. 
Discussion. To our knowledge, this is the first report in 
the English literature on patients undergoing surgical 
resection for diaphragmatic invasion. It is possible that the 
reason for the rarity of this condition is that many patients 
have late disease in the form of T4 tumors with malignant 
pleural effusion when first referred for treatment. Because 
resectable lung cancer invading the diaphragm is a rare 
entity (only 0.17% of all patients having exploratory 
operations), very little information is available on the 
proper management strategy. In our series, diaphragmatic 
invasion was not suspected before the operation. Most 
patients had symptoms related to lung cancer but none 
had symptoms that could point the surgeon to the dia- 
phragm (shoulder pain, for example). Technically, in six of 
seven patients the diaphragm was reconstructed by pri- 
mary repair; only one patient (patient 5) required mesh 
reconstruction. It is interesting that practically all patients 
had squamous cell carcinoma, whereas one would expect 
that adenocarcinoma would comprise at least half of all 
specimens. Most patients underwent some form of pul- 
monary resection, although one patient could not with- 
stand resection. This patient was treated with radiation 
and chemotherapy and survived 28 weeks. Four patients 
had N2 disease, discovered uring exploration, and all 
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Table I. Demographics 
Age Survival 
Patient Sex (yr) Stage Status (wk) Cause of death 
1 F 69 T3 N2 DOD 23 Brain metastasis 
2 M 62 T3 N2 DOD 103 Brain metastasis 
3 M 53 T3 N2 DOD 28 Generalized 
disease 
4 F 64 T3 N2 DOD 170 Brain metastasis 
5 M 52 T3 NO DOC 17 Arrhythmia 
6 F 82 T3 NO DOC 7 MI 
7 M 75 T3 NO DOC 5 MVA 
8 M 67 T3 NO NED 69 
DOD, Died of disease; DOC, died of other causes; NED, no evidence of
disease; MI, Myocardial infarction; MVA, motor vehicle accident. 
died of distant disease. Detection of N2 disease becomes 
of paramount importance in view of recent data suggest- 
ing that preoperative chemotherapy improves urvival in 
such patients. 4' 5 Our follow-up on patients without in- 
volved mediastinal nodes is disappointing, because three 
of four patients died relatively soon after the operation of 
causes unrelated to their lung cancer. To our knowledge, 
none had evidence of disease at the time of death. 
Postoperative follow-up in the single patient who is free of 
disease is only 69.4 weeks. 
In summary, resectable tumors invading the diaphragm 
are rare. Careful evaluation of the mediastinum with 
mediastinoscopy is important to detect N2 disease and 
select hose patients for preoperative chemotherapy. Most 
tumors found to invade the diaphragm during surgery can 
be resected and the diaphragm closed primarily. The 
survival benefit of resecting the tumor in patients with 
diaphragmatic invasion is not clear. Because this is an 
unusual entity, it may be difficult to determine whether 
surgery is the adequate treatment modality. We believe 
that in patients without involved mediastinal nodes and in 
good general condition, diaphragmatic invasion should be 
treated by resecting the tumor en bloc with the dia- 
phragm. 
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PULMONARY ROOT TRANSLOCATION FOR BIVENTRICULAR REPAIR OF DOUBLE-OUTLET 
LEFT VENTRICLE WITH ABSENT SUBPULMONIC CONUS 
Doff B. McElhinney, MS, V. Mohan Reddy, MD, and Frank L. Hanley, MD, San Francisco, Calif. 
Double-outlet left ventricle (DOLV) is a rare form of 
malpositioned great arteries in which the aorta and the 
main pulmonary artery arise from the left ventricle in the 
presence of a malalignment ventricular septal defect. 
From the Division of Cardiothoracic Surgery, University of 
California, San Francisco, San Francisco, Calif. 
Received for publication Jan. 23, 1997; accepted for publication 
March 4, 1997. 
Address for reprints: V. Mohan Reddy, MD, Division of Cardio- 
thoracic Surgery, 505 Parnassus Ave., M593, San Francisco, 
CA 94143-0118. 
J Thorac Cardiovasc Surg 1997;114:501-3 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/54/81584 
DOLV occurs as a spectrum and has been found with a 
variety of associated lesions, most commonly pulmonic or 
subpulmonic stenosis (or both), tricuspid valve anomalies, 
and hypoplasia of the right ventricle. 1 Depending on the 
size and function of the right ventricle and tricuspid valve, 
along with the size and position of the ventricular septal 
defect, DOLV is usually amenable to biventricular repair. 
Traditionally, this has been accomplished by either an 
intraventricular baffle procedure or ventricular septal 
defect closure with conduit reconstruction of the right 
ventricular outflow tract (Rastelli repair). 2' 3 The former 
technique isnot suitable for all forms of DOLV, especially 
those with a restrictive interventricular communication r 
subpulmonic stenosis. The Rastelli approach is subopti- 
mal, especially in children, because they will almost inev- 
itably outgrow their conduit and require conduit replace- 
